| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 282,298 | 253,632 | 110,531 | 365,201 | | Cost of Revenue | 239,939 | 217,767 | 98,649 | 323,288 | | | Gross Profit | 42,359 | 35,865 | 11,882 | 41,913 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 37,017 | 38,547 | 28,158 | 47,032 | | Non Recurring | 690 | 2,190 | 15,502 | 52,653 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,652 | (4,872) | (31,778) | (57,772) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 976 | 5,705 | (1,966) | (1,656) | | Earnings Before Interest And Taxes | 5,628 | 833 | (33,744) | (59,428) | | Interest Expense | 9,643 | 5,459 | 3,323 | 4,216 | | Income Before Tax | (4,015) | (4,626) | (37,067) | (63,644) | | Income Tax Expense | 871 | 1,016 | 2,751 | (7,166) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,886) | (5,642) | (39,818) | (56,478) | | | Non-recurring Events | | Discontinued Operations | (1,571) | (8,861) | (7,298) | 421 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,457) | (14,503) | (47,116) | (56,057) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,457) | ($14,503) | ($47,116) | ($56,057) |
|
0.08% Nasdaq 
0.38%
Income Statement
